A controversial ER negative PR positive molecular subtype of breast carcinoma-Report of two cases
Breast Dis. 2023;42(1):315-318. doi: 10.3233/BD-230039.ABSTRACTER-/PR+ is a controversial subtype and is not formally recognised as molecular subtype of breast carcinoma. Few studies concluded that this subtype does not exist and is due to technical errors, however, in contrast others consider it to be distinct entity with different response to therapy and clinical outcome. It is also essential to know whether this subtype shows any distinct histomorphological features or prognosis.Therefore, the present two cases of controversial subtype ER-/PR+ breast cancer is being reported with both the cases showing neuroendocrinal differentiation.PMID:37807774 | DOI:10.3233/BD-230039
Source: Breast Disease - Category: Cancer & Oncology Authors: Smita Chandra Sanya Bhasin Sunil Saini Source Type: research
More News: Brain | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Neurology | Study